[1] |
Zhao Yue, Ruan Xiangyan, Cheng Jiaojiao, Gu Muqing, Xu Xin, Wang Yuejiao.
Breast cancer pathological diagnosis reveals correlation between progesterone receptor membrane component 1 and clinicopathological parameters
[J]. Journal of Capital Medical University, 2022, 43(3): 350-356.
|
[2] |
Yang Yu, Ruan Xiangyan, Ju Rui, Xu Xin, Gu Muqing, Cheng Jiaojiao.
Effect of drospirenone/ethinylestradiol(Ⅱ) on serum anti-Müllerian hormone level in Chinese polycystic ovary syndrome women
[J]. Journal of Capital Medical University, 2021, 42(4): 547-552.
|
[3] |
Min Min, Ruan Xiangyan, Wang Husheng, Cheng Jiaojiao, Luo Suiyu, Xu Zhongting, Li Meng, Alfred O. Mueck.
Effects of orlistat comprehensive intervention on metabolic syndrome and its components in overweight or obese polycystic ovarian syndrome patients
[J]. Journal of Capital Medical University, 2020, 41(4): 514-519.
|
[4] |
Zhang Lingyan, Ruan Xiangyan, Cai Guiju, Gu Muqing, Alfred O. Mueck.
Effect of tamoxifen on Ki-67 expression in breast tumor tissue of nude mice transfected with progesterone receptor membrane component 1
[J]. Journal of Capital Medical University, 2019, 40(4): 533-538.
|
[5] |
Min Min, Ruan Xiangyan, Zhao Yue, Wang Husheng, Cheng Jiaojiao, Luo Suiyu, Xu Zhongting, Li Meng, Zhang Luping, Wang Yuejiao, Alfred O. Mueck.
Effect of orlistat combined intervention on androgen and glycolipid metabolism in overweight or obese polycystic ovary syndrome patients
[J]. Journal of Capital Medical University, 2019, 40(4): 572-577.
|
[6] |
Li Xue, Ruan Xiangyan, Gu Muqing, Cai Guiju, Zhao Yue, Alfred O. Meuck.
Progesterone receptor membrane component 1 increases hormone induced proliferation of breast cancer cells——E2 vs sequential combination vs continuous combination
[J]. Journal of Capital Medical University, 2019, 40(2): 237-243.
|
[7] |
Zhang Ying, Ruan Xiangyan, Cai Guiju, Su Yajie, Li Na, Alfred O. Mueck.
Different hormone receptors and their roles as prognostic markers in breast cancer
[J]. Journal of Capital Medical University, 2018, 39(4): 479-485.
|
[8] |
Zhao Yue, Ruan Xiangyan, Zhang Quandong, Wang Husheng, Li Xue, Cai Guiju, Gu Muqing, Alfred O. Mueck.
Correlation between the blood membrane-bound progesterone level and clinical application in patients with breast cancer
[J]. Journal of Capital Medical University, 2018, 39(4): 486-493.
|
[9] |
Wang Lijuan, Ruan Xiangyan, Zhao Yue.
Expression of PGRMC1 in breast cancer tissue and its correlation with clinicopathological features
[J]. Journal of Capital Medical University, 2018, 39(2): 272-276.
|
[10] |
Wang Lijuan, Yang Chun, Gu Muqing, Pierre Hardy, Ruan Xiangyan, Alfred O. Mueck.
Relationship between progesterone-regulated microRNAs and breast cancer
[J]. Journal of Capital Medical University, 2017, 38(4): 521-525.
|
[11] |
Zhang Ying, Ruan Xiangyan, Alfred O. Mueck.
Progress in research on possible role of progesterone receptor membrane component 1(PGRMC1) in the mechanism of breast cancer development
[J]. Journal of Capital Medical University, 2015, 36(4): 583-587.
|
[12] |
Zhang Ying, Ruan Xiangyan, Mi Xin, Wang Gangyue, Alfred O. Mueck.
Study of prognostic impact of progesterone receptor membrane component 1 (PGRMC1) in breast cancer patients
[J]. Journal of Capital Medical University, 2015, 36(4): 548-552.
|
[13] |
Adolf E. Schindler.
Progestogens and early pregnancy:prevention and treatment
[J]. Journal of Capital Medical University, 2013, 34(4): 492-493.
|
[14] |
ZHANG Junli, RUAN Xiangyan.
Progestogens and early pregnancy:prevention and treatment
[J]. Journal of Capital Medical University, 2013, 34(4): 494-495.
|
[15] |
ZHANG Ying, RUAN Xiangyan, TIAN Xuanxuan, ZHANG Junli, Alfred O. Mueck.
Development of progesterone receptor membrane component 1(PGRMC1) on the risk of breast cancer
[J]. Journal of Capital Medical University, 2013, 34(4): 496-500.
|